TinyGemsBreaks Archive - Page 86 of 125

TuesdayDec 27, 2022 11:54 am

TinyGemsBreaks – Vision Energy Corp. (VENG) Increases Core Team to Realize Project Development Objectives

Vision Energy (OTCQB: VENG) today provided an update on the expansion of its project management and development team. According to the announcement, Vision Energy, through its wholly owned Dutch subsidiary Evolution Terminals BV (“ETBV”), continues work to realize its project development objectives and has increased its core team of experienced commercial and engineering professionals. Since its December 2020 incorporation, ETBV has been executing its mission to design and develop a pioneering Green Energy Hub for renewable products, hydrogen carriers and low-carbon fuels. In March 2021, ETBV engaged professionals from Rotterdam-based Riverlake Solutions, a specialist project development and engineering consultancy to…

ThursdayDec 22, 2022 11:31 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces I-GO European Arrival

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its I-GO(TM) Commercial Urban Delivery EV has arrived in Europe; specifically, sample vehicles are on their way to Ireland-based Newgate Motor Group, with an expected delivery for early next month. Initially, delivery was scheduled for December, but COVID-related shutdown issues caused the delay. According to the announcement, Mullen’s I-GO is an urban commercial delivery vehicle designed to meet the growing demand for quick deliveries in dense cities throughout Europe that have space constraints; the I-GO is EU standard homologated, certified, and ready for sale in initial markets…

WednesdayDec 21, 2022 3:59 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys ASR and Emergency Communication Services for Five New Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced continued market expansion through securing five new contracts for its Autonomous Security Robot (“ASR”) and Blue Light Emergency Communication services across multiple U.S. states. The contracts and deployment locations include a property management group in Chicago, a police department in North Carolina, another tribal casino client in Oklahoma, an airport in New Jersey, as well as a construction company in Texas. The announcement reads, “Knightscope’s expanded product line is helping its clients protect the places people live, work, study and visit in many new ways. In addition to…

WednesdayDec 21, 2022 2:42 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD (TM) Achieves Superior CBD Blood Absorption Levels in Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has demonstrated superior cannabidiol (“CBD”) blood absorption levels from its patented DehydraTECH-CBD(TM) relative to those of published, pharmaceutical-grade CBD industry comparators. The results were obtained from the company’s recently completed, multi-week human clinical hypertension study – HYPER-H21-4. “DehydraTECH-CBD has repeatedly shown that it can be administered at much lower dose levels than other CBD formulations to achieve effective levels within the blood stream, as supported by this pharmaceutical-industry peer comparison,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “This is extremely important to patients…

WednesdayDec 21, 2022 1:57 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Issues Development Update on Green Energy Hub

Vision Energy (OTCQB: VENG) today provided a project development update on the company’s Green Energy Hub in the North Sea Port of Vlissingen, the Netherlands. According to the update, Vision Energy, through its wholly owned subsidiary Evolution Terminals BV, is concluding remaining requisite studies to support filing permit applications under the Dutch “WABO” process, with targeted first submission by Dec. 31, 2022. The submission includes filing of an environmental permit followed by construction permit application for phase 1 400,000 cubic meters (“CBM”) capacity. The latter will be a phased submission, with each phase designed in accordance with commercial storage requirements…

TuesdayDec 20, 2022 3:25 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection…

TuesdayDec 20, 2022 12:08 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 21st Annual J.P. Morgan Tech/Auto Forum

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 21st Annual J.P. Morgan Tech/Auto Forum. The forum is slated to take place at the Bellagio Hotel during CES 2023 in Las Vegas, Nevada, on Jan. 5, 2023. Cepton will participate in a fireside chat at the event at 2:20 p.m. PT on Thursday, Jan. 5. Interested parties should visit https://ibn.fm/2Sfvm to view a live audio webcast of the presentation. To view the full press release,…

TuesdayDec 20, 2022 11:37 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Wraps Up 2022 Mullen FIVE Strikingly Different Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, finished its innovative 2022 Mullen FIVE Strikingly Different Test Drive Tour with a last stop on Dec. 16, 2022, in Charlotte, North Carolina. The tour began Oct. 27, 2022, and featured stops in nine cities in the west, south, and southeastern parts of the country. According to the announcement, the tour was very successful; the company is already planning a follow-up spring tour with stops planned throughout the eastern, northwest and Midwest parts of the country. The fall tour featured the Mullen Five; the spring tour will feature the Mullen…

TuesdayDec 20, 2022 11:12 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO Highlights 2022 as ‘Momentous Year’

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary of its key milestone accomplishments in 2022. “2022 was a momentous year marked by steady progress across our pipeline of differentiated psychedelic-based therapeutics and partnerships targeting mental health. Most notable were the advancements of our two lead programs, CYB003 and CYB004, into clinical stage – within less than 18 months since discovery – which is a remarkable accomplishment and a true testament to the strength of our team,” said Cybin’s Chief Executive Officer Doug Drysdale. “Along with our clinical programs,…

FridayDec 16, 2022 3:18 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Expected to Yield Notable Results in Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs. “Lexaria [recently] announced that the study program DIAB-A22-1 [had begun] on schedule, making it the company’s first-ever study to investigate whether its DehydraTECH-processed cannabidiol (‘CBD’) may potentially have therapeutic utility against diabetes,” a recent article reads. “Lexaria is optimistic that its DehydraTECH-CBD will yield notable results from this study, especially having met primary safety and efficacy objectives from its HYPER-H21-4 clinical study. There is a strong connection between heart disease, hypertension and diabetes, with hypertension proving to…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks